Forum Private Client Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-484
Closed -$210K 81
2025
Q1
$210K Buy
+484
New +$194K 0.09% 74
2024
Q4
Sell
-432
Closed -$225K 77
2024
Q3
$225K Sell
432
-2
-0.5% -$1.07K 0.1% 72
2024
Q2
$235K Hold
434
0.11% 67
2024
Q1
$225K Hold
434
0.11% 65
2023
Q4
$205K Buy
+434
New +$201K 0.11% 69
2023
Q3
Sell
-462
Closed -$205K 22
2023
Q2
$205K Sell
462
-1
-0.2% -$461 0.12% 69
2023
Q1
$213K Sell
463
-2
-0.4% -$952 0.13% 68
2022
Q4
$239K Sell
465
-20
-4% -$10.2K 0.16% 61
2022
Q3
$220K Sell
485
-59
-11% -$28.2K 0.16% 62
2022
Q2
$263K Hold
544
0.19% 56
2022
Q1
$267K Buy
+544
New +$249K 0.21% 55

Other funds holding ELV

Forum Private Client Group's ELV Position: Q2 2025 in Review

Forum Private Client Group sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 484 shares — an estimated $210K sold.

Forum Private Client Group first reported a position in ELV in Q1 2022 and held it in 11 quarters. The position peaked at $267K in Q1 2022. 1,589 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

  • Forum Private Client Group reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
  • Forum Private Client Group sold 484 Elevance Health shares in Q2 2025, an estimated $210K.
  • Forum Private Client Group first reported a position in Elevance Health in Q1 2022 and held it in 11 quarters.
  • Forum Private Client Group's Elevance Health position peaked at $267K in Q1 2022.
  • 1,589 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on Forum Private Client Group's 13F filing for Q2 2025, filed 12 Aug 2025.